Brief: Toleranzia Selects CRL For GLP Toxicology Study Of Its Drug Candidate TOL2
27/12/2022 14:59
Dec 27 (Reuters) - Toleranzia AB TOLE.ST :
* TOLERANZIA SELECTS CHARLES RIVER LABORATORIES FOR GLP
TOXICOLOGY
STUDY OF ITS DRUG CANDIDATE TOL2
Source text for Eikon: ID:nMFN1ghtYh
Further company coverage: TOLE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Toleranzia AB
See all newsBrief: Swedish Companies Registration Office Permits Implementation of Flerie, Toleranzia's M&A
Brief: Toleranzia Q2 Net Income SEK -2.911 Million
Brief: Nasdaq Stockholm Approves Toleranzia’S Application For Delisting
Brief: Toleranzia Applies For Delisting Of Shares On Nasdaq
Brief: Toleranzia Approves Merger Plan Adopted By Boards Of Toleranzia, Flerie